Literature DB >> 20458285

Biomarker-led adaptive trial blazes a trail in breast cancer.

Malorye Allison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20458285     DOI： 10.1038/nbt0510-383

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Clinical application of the 70-gene profile: the MINDACT trial.

Authors:  Fatima Cardoso; Laura Van't Veer; Emiel Rutgers; Sherene Loi; Stella Mook; Martine J Piccart-Gebhart
Journal:  J Clin Oncol       Date:  2008-02-10       Impact factor: 44.544

2.  Bayesian clinical trials: no more excuses.

Authors:  Mithat Gönen
Journal:  Clin Trials       Date:  2009-06       Impact factor: 2.486

3.  A gene-expression signature as a predictor of survival in breast cancer.

Authors:  Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke Witteveen; Annuska Glas; Leonie Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

4.  Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center.

Authors:  Swati Biswas; Diane D Liu; J Jack Lee; Donald A Berry
Journal:  Clin Trials       Date:  2009-06       Impact factor: 2.486
  4 in total
  6 in total

1.  Reinventing clinical trials.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

2.  Turning the tide in lung cancer.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

3.  Can cancer clinical trials be fixed?

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

4.  Master Protocol for squamous cell lung cancer readies for launch.

Authors:  Jeffrey L Fox
Journal:  Nat Biotechnol       Date:  2014-02       Impact factor: 54.908

5.  In vivo method to monitor changes in HER2 expression using near-infrared fluorescence imaging.

Authors:  Moinuddin Hassan; Victor Chernomordik; Rafal Zielinski; Yasaman Ardeshirpour; Jacek Capala; Amir Gandjbakhche
Journal:  Mol Imaging       Date:  2012-06       Impact factor: 4.488

6.  Randomized test-treatment studies with an outlook on adaptive designs.

Authors:  Werner Vach; Antonia Zapf; Amra Hot; Patrick M Bossuyt; Oke Gerke; Simone Wahl
Journal:  BMC Med Res Methodol       Date:  2021-06-01       Impact factor: 4.615
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.